STOCKSCOPE

Nuix (ASX: NXL) Attracts $945 Million Takeover Proposal at 73% Premium. Could Its Software Growth Be Worth Even More?

Danny Aad

Danny Aad

Technology & Biotechnology Specialist | StockScope

Published:3d ago
Nuix (ASX: NXL) Attracts $945 Million Takeover Proposal at 73% Premium. Could Its Software Growth Be Worth Even More?

A potential $945 million takeover has placed Nuix Limited (ASX: NXL) in the spotlight, with US private equity firm Haveli Investments proposing a $2.75-per-share cash acquisition, representing a 73% premium to the company's previous closing price.

The approach comes at an encouraging time for Nuix, following stronger earnings, improving cash generation and rapid adoption of its next-generation investigative software platform.

With the business delivering increasingly compelling financial results, the question is whether Haveli's proposal fully captures Nuix's longer-term growth potential.

Key Numbers

  • $2.75 per share: Haveli's conditional, non-binding indicative acquisition proposal, valuing Nuix at approximately $945 million.
  • 73% premium: Above Nuix's $1.59 closing share price on 17 November 2026.
  • $263.2 million: FY26 revenue, increasing 18.8% year-on-year.
  • $59.8 million: FY26 adjusted management EBITDA, rising 60.4%.
  • $37.4 million: FY26 free cash flow, compared with $4 million in FY25.

The Latest Development: A Major Vote of Confidence

On 18 November 2026, Nuix confirmed it had entered into a process and exclusivity deed with Haveli Investments Software Fund I following an unsolicited indicative acquisition proposal.

The proposed transaction would see Haveli acquire all outstanding Nuix shares through a scheme of arrangement.

Haveli's interest follows earlier approaches beginning in July 2026, with negotiations progressing towards the current $2.75-per-share proposal.

The parties have agreed to a five-week exclusivity period, allowing Haveli to complete due diligence and negotiate a potential binding agreement.

Nuix's largest shareholder, Macquarie Corporate Holdings, which owns approximately 28% of the company, supports entering the process deed.

The proposal remains conditional and non-binding, but it highlights the strategic appeal of Nuix's technology, established customer relationships and improving financial performance.

What Stands Out: Profitability and Cash Flow Are Accelerating

Nuix enters takeover discussions with considerably stronger financial fundamentals.

FY26 revenue increased 18.8% to $263.2 million, while adjusted management EBITDA surged 60.4% to $59.8 million.

Statutory net profit reached $16.4 million, reversing the previous year's $9.2 million loss.

Perhaps most encouragingly, free cash flow strengthened to $37.4 million from $4 million in FY25.

The company also finished June 2026 with $49.9 million in net cash, providing financial flexibility to support continued product development.

Based on approximately $945 million in equity value, the proposed acquisition implies an enterprise value of roughly $895 million after adjusting for reported net cash.

That represents approximately 3.4 times FY26 revenue and 15 times adjusted management EBITDA.

These multiples provide an important valuation reference, particularly as Nuix continues expanding its recurring software business.

What the Company Is Doing Now

Nuix is strengthening its competitive position through Nuix Neo, its integrated investigative analytics platform.

Neo's annualised contract value increased 179% to $78.5 million in FY26, reaching 135 customers and accounting for approximately 30% of total annualised contract value.

The company also completed its acquisition of Linkurious in April 2026, adding advanced graph visualisation capabilities and expanding potential cross-selling opportunities.

For FY27, management is targeting annualised contract value of $285 million to $300 million.

Nuix is also accelerating research and development expenditure by approximately $15 million to strengthen product capabilities and support future growth.

While this investment is expected to moderate near-term earnings expansion, it could reinforce Nuix's competitive positioning in complex data investigations and analytics.

Insight: Could Nuix's Growth Potential Exceed the Takeover Valuation?

We see Nuix's improving financial performance and expanding software platform as compelling strengths behind Haveli's acquisition interest. Stronger profitability, substantial free cash flow growth and Neo's rapid adoption suggest the business is building a more scalable earnings foundation. The proposed 73% premium provides meaningful recognition of that progress, although it does not establish full standalone value. Organic annualised contract value growth of 8.6% remains an important measure of underlying momentum. We believe sustained contract growth, successful product integration and improving cash conversion could strengthen Nuix's longer-term valuation case beyond the immediate takeover discussions.

What Happens Next?

The immediate focus is whether Haveli completes due diligence and submits a binding proposal following the five-week exclusivity period.

Any transaction would still require definitive agreements, regulatory approvals and shareholder approval.

Beyond the potential acquisition, Nuix's FY27 annualised contract value target of $285 million to $300 million provides an important benchmark for continued commercial momentum.

With stronger cash generation, expanding software capabilities and a substantial takeover proposal, Nuix enters its next phase from an increasingly attractive financial and strategic position.

Danny Aad

Danny Aad

(Technology & Biotechnology Specialist | StockScope)

Danny Aad is an experienced technology executive with a distinguished career spanning more than three decades, including senior leadership positions as Chief Technology Officer (CTO) across the technology and biotechnology sectors. With extensive expertise in technology strategy, digital innovation and the evolving biotechnology landscape, Danny brings a wealth of industry knowledge and technical insight to his analysis of emerging technologies, corporate developments and investment opportunities.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX slides to five-month low as AI sell-off rattles global markets
Market Briefings
Market Briefings

ASX slides to five-month low as AI sell-off rattles global markets

Australian equities: what moved the ASX 200? Australian shares extended their losing streak on Friday, with the S&P/ASX 200 falling 137.8 points, or 1.58%, to close at 8,592.6. This marked...

Mark ElzayedMark Elzayed•
NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play
Technology
Technology

NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play

NEXTDC Limited ASX: NXT has delivered an encouraging upgrade to its FY27 earnings guidance, highlighting the strength of its broader data centre business despite electricity supply delays at...

Danny AadDanny Aad•
Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential
Mining
Mining

Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential

A standout 25-metre intersection grading 31.4% manganese has delivered another encouraging result for Trek Metals Limited ASX: TKM, strengthening the exploration potential of its Kuro discov...

Alison ElzayedAlison Elzayed•
EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges
Biotech & Health
Biotech & Health

EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges

EBR Systems ASX: EBR has taken another significant step towards expanding the commercial reach of its wireless heart pacing technology, with US Medicare authorities proposing national covera...

Danny AadDanny Aad•
Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches
Mining
Mining

Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches

Orion Minerals ASX: ORN has reached a significant turning point in its copper and zinc development strategy, receiving its first US$6.7 million payment from global mining group Glencore. The...

Alison ElzayedAlison Elzayed•
EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development
Biotech & Health
Biotech & Health

EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development

EMVision Medical Devices ASX: EMV is building momentum towards a potentially significant commercial breakthrough, with a fresh $306,750 government grant payment supporting the expansion of i...

Danny AadDanny Aad•
Loading more stories...